Literature DB >> 11172533

Overview of the past contributions of animal models and their changing place in psychiatry.

W T McKinney1.   

Abstract

Research utilizing animal models has been responsible for major advances in understanding psychiatric disorders. The first data based integrative theories of psychopathology grew largely out of animal research. A variety of animal models that have been developed have been critical in broadening our understanding of human development and in providing empirical support for the importance of early experiences for behavioral and neurobiologic development. The development of many widely used clinical psychopharmacologic agents has depended on the use of animal models. The above examples represent substantive contributions of animal models to investigations of fundamental aspects of psychopathology. There is no "perfect," complete or comprehensive single animal model for any specific psychiatric disorder and contentious debates about the validity and/or usefulness of specific animal models persist. Animal models of diseases in medicine need to be understood in a historical and evolutionary perspective and their advantages as well as limitations recognized. There will likely never be an animal model in any field of medicine that is a perfect fit with the human condition, rather the emphasis in the development and study of disease models in animals needs to be on specific components of the human illness. Neither overextended cross-species comparisons nor unjustified negativism about animal models seems defensible. A major challenge in the continuing development and use of biobehavioral animal models in psychiatry is their relationship to the molecular neurosciences, including genetics, in understanding the mechanisms of mental disorders. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11172533     DOI: 10.1053/scnp.2001.20292

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN: 1084-3612


  10 in total

Review 1.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

3.  Modeling binge-like ethanol drinking by peri-adolescent and adult P rats.

Authors:  Richard L Bell; Zachary A Rodd; Rebecca J Smith; Jamie E Toalston; Kelle M Franklin; William J McBride
Journal:  Pharmacol Biochem Behav       Date:  2011-07-29       Impact factor: 3.533

4.  Delay discounting in C57BL/6J and DBA/2J mice: adolescent-limited and life-persistent patterns of impulsivity.

Authors:  Jonathan W Pinkston; R J Lamb
Journal:  Behav Neurosci       Date:  2011-04       Impact factor: 1.912

Review 5.  Sex-Specific Brain Transcriptional Signatures in Human MDD and Their Correlates in Mouse Models of Depression.

Authors:  Maureen Touchant; Benoit Labonté
Journal:  Front Behav Neurosci       Date:  2022-05-03       Impact factor: 3.617

6.  Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats.

Authors:  Richard L Bell; Bill J A Eiler; Jason B Cook; Shafiqur Rahman
Journal:  Alcohol       Date:  2009-12       Impact factor: 2.405

Review 7.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 8.  Scheduled access alcohol drinking by alcohol-preferring (P) and high-alcohol-drinking (HAD) rats: modeling adolescent and adult binge-like drinking.

Authors:  Richard L Bell; Zachary A Rodd; Eric A Engleman; Jamie E Toalston; William J McBride
Journal:  Alcohol       Date:  2013-10-31       Impact factor: 2.405

Review 9.  The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.

Authors:  E A Engleman; Z A Rodd; R L Bell; J M Murphy
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

Review 10.  Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy.

Authors:  Vasileios Boulougouris; Ioannis Malogiannis; George Lockwood; Iannis Zervas; Giuseppe Di Giovanni
Journal:  Exp Brain Res       Date:  2013-08-23       Impact factor: 1.972

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.